New drug combo aims to outperform standard care in Hard-to-Treat myeloma
NCT ID NCT05028348
First seen Jan 11, 2026 · Last updated May 10, 2026 · Updated 18 times
Summary
This study tests a new three-drug combination (selinexor, pomalidomide, and dexamethasone) against another standard combination (elotuzumab, pomalidomide, and dexamethasone) in 117 adults with multiple myeloma that has come back or stopped responding to prior treatments. Participants must have had 1 to 4 prior therapies. The goal is to see which combo delays cancer growth longer and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens
Athens, Greece
-
CHRU Hôtel Dieu
Nantes, France
-
CHU Hôpital Saint Antoine
Paris, France
-
Clínica Universidad de Navarra (CUN)
Pamplona, Spain
-
Complejo Hospitalario Universitario de Santiago (CHUS)
Santiago de Compostela, Spain
-
H. General Universitario Morales Meseguer
Murcia, Spain
-
H. Universitario Marqués de Valdecilla
Santander, Spain
-
H.U. La Fe
Valencia, Spain
-
Hospital Clinic I Provincial de Barcelona
Barcelona, Spain
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Hospital Universitario 12 de Octubre
Madrid, Spain
-
Hospital Universitario de Salamanca
Salamanca, Spain
-
Hospital de Cabueñes
Gijón, Spain
-
Institut Catala D Oncolocia Hospitalet - Hospital Duran i Reynals
Barcelona, Spain
-
Institut Català D'Oncologia - Hospital Dr. Josep Trueta
Girona, Spain
-
Klinikum Chemnitz
Chemnitz, Germany
-
La Pitié
Paris, France
-
Marien Hospital Dusseldorf
Düsseldorf, Germany
-
University Medicine Greifswald, Medical Clinic and Polyclinic for Internal Medicine
Greifswald, Germany
-
Universitätsklinikum Hamburg - Eppendorf
Hamburg, Germany
Conditions
Explore the condition pages connected to this study.